Nestmedic

Nestmedic Receivables

The Accounts Receivable of Nestmedic (NST.WA) as of Oct 30, 2026 is 318,900.00 PLN. In the previous year, Accounts Receivable was 37,300.00 PLN — a change of 754.96% (higher).

Receivables

318,900.00PLN

YoY

754.96%

Last updated:

Accounts Receivable of Nestmedic is 2025 318,900.00 PLN. Accounts Receivable of Nestmedic was 2024 37,300.00 PLN. It decreases by 754.96% higher compared to the previous year.

The Nestmedic Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2018
52,800.00 PLN
Jan 1, 2019
191,400.00 PLN
Jan 1, 2020
51,900.00 PLN
Jan 1, 2021
477,600.00 PLN
Jan 1, 2022
868,900.00 PLN
Jan 1, 2023
105,600.00 PLN
Jan 1, 2024
37,300.00 PLN
Jan 1, 2025
318,900.00 PLN
The Nestmedic Receivables history
YEARReceivablesYoY
318,900.00PLN+754.96%
37,300.00PLN-64.68%
105,600.00PLN-87.85%
868,900.00PLN+81.93%
477,600.00PLN+820.23%
51,900.00PLN-72.88%
191,400.00PLN+262.50%
52,800.00PLN-2.22%
54,000.00PLN+119.51%
24,600.00PLN+129.91%
10,700.00PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nestmedic Stock analysis

What does Nestmedic do? Nestmedic SA generates revenue through the sale of its Pregnabit telemedicine CTG device, which includes the display device, fetal heart rate probe, wrist heart rate monitor, tocodynamometer probe, and fetal movement marker. The company targets healthcare providers and clinics that require home-based fetal monitoring solutions, enabling pregnant women to conduct CTG tests independently. Medical Telemonitoring Center (MTC) processes the wireless data from Pregnabit, providing medical analysis and opinions to users. Nestmedic SA's product is designed for direct consumer use in home settings with professional medical oversight. The Pregnabit solution is marketed to healthcare institutions seeking to offer remote fetal health monitoring services. By eliminating the need for in-person specialist visits, the device supports cost-effective maternal care. MTC serves as the central hub for data analysis, ensuring medical professionals can interpret results and deliver timely advice without direct patient interaction. Nestmedic SA focuses on the development and production of this integrated telemedicine system for fetal monitoring. Nestmedic SA's business model relies on selling the Pregnabit device and associated hardware to healthcare facilities. The wireless transmission of data to MTC allows for continuous medical supervision without requiring patients to visit clinics. The company's core offering combines hardware, software, and medical analysis services to provide a comprehensive solution for home-based fetal health monitoring. Nestmedic is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nestmedic stock

Accounts Receivable of Nestmedic is 318,900.00 PLN in 2025.

Accounts Receivable of Nestmedic changed from 37,300.00 PLN to 318,900.00 PLN, representing a 754.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable Nestmedic since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's Nestmedic historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Nestmedic

All Key Metrics — Nestmedic